HOME >> BIOLOGY >> NEWS
Live reporting

New findings show an iron storage molecule in the cell can serve as an advanced tool for mapping gene expression. Future gene therapy may use a technique in which non-invasive magnetic resonance imaging (MRI) is used to track this molecule. The results of this research, conducted by Prof. Michal Neeman of the Weizmann Institute's Biological Regulation Department, were published in the research journal Neoplasia.

Neeman, together with Dr. Batya Cohen of the Institute's Molecular Genetics Department, developed the capacity of the iron-bearing ferritin molecule to serve as a sort of gene "spy" by making genetic modifications to cells. This approach rendered ferritin sensitive to tetracycline (TET), a common antibiotic, so that when TET is present, the ferritin is "off" and when TET is absent, ferritin is "on." Tumor cells with modified ferritin were inserted into living mice and then tracked with MRI. The researchers hampered the expression of ferritin in the inserted cells through the administration of TET. When they stopped the TET, the "switch" turned on, triggering ferritin molecules to increase their numbers, thereby causing an increase in iron uptake within the tumor cells. The contrast between the iron content in these and in the normal surrounding cells showed up in the MRI (which is sensitive to magnetic particles such as iron), effectively identifying the genetically modified cells.

This method grew out of a joint vision that originated 10 years ago in collaboration with the late Dr. Yoav Citri. Ferritin's advantage is that it is visible in MRI without the need for an additional contrast material. This technique has far-reaching implications for monitoring the progress of gene therapy, such as that used to reactivate the body's production of insulin in the treatment of diabetes, because the genes can be "tagged" prior to injection. Therapeutic genes can then be tracked by MRI to ensure the target is reached and the desired activations occur.
'"/>

Contact: Alex Smith
asmith@jgordonassociates.com
212-367-3892
American Committee for the Weizmann Institute of Science
9-May-2005


Page: 1 2

Related biology news :

1. Fish with chips reporting from ocean top highlights at Census of Marine Life mid-point
2. Biased reporting found in cancer prognostic studies

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/3/2019)... ... 02, 2019 , ... Personalized Stem Cells, Inc (“PSC”), a human ... approved clinical trial for stem cell treatment of knee osteoarthritis . The successful enrollment ... a subsidiary of VetStem Biopharma. , PSC CEO, Michael Dale, stated, “We are proud ...
(Date:9/30/2019)... ... September 30, 2019 , ... RoosterBio ... stem/stromal cell (hMSC) biomanufacturing systems, today announced it has received patent approval ... formats (patent number AU 2015259373). This new patent adds intellectual property (IP) ...
(Date:9/25/2019)... ... September 25, 2019 , ... Deep Science Ventures (DSV), a ... world’s largest independent funder of cancer research. , Deep Science Ventures was founded to ... view of the opportunity from the start, both at the industry and biological level. ...
Breaking Biology News(10 mins):
(Date:10/10/2019)... ... 2019 , ... VirTrial today announced an alliance ... All Pratia research centers have completed VirTrial’s Virtual Trial Capable training, making them ... Trial Capable and prepared to conduct decentralized clinical trials (DCT). , The training ...
(Date:10/8/2019)... ... October 07, 2019 , ... Erchonia Corporation, the global leader ... announces that the U.S. Food and Drug Administration (FDA) has granted the company ... relief of chronic neck and shoulder pain of musculoskeletal origin. , Erchonia continues ...
(Date:10/3/2019)... ... 01, 2019 , ... Today Cereset®, the only proven non-invasive ... of its randomized research trial for individuals with persisting symptoms following mild-Traumatic Brain ... a non-invasive technology which compares tones delivered to a subject’s brain guided by ...
(Date:10/3/2019)... ... October 02, 2019 , ... ... sciences leadership firm that is enabling clinical program outsourcing success by cultivating radical ... award-winning pharma and biotech veteran executive Brenda Reese, phaseUP™ brings clients deep, broad ...
Breaking Biology Technology:
Cached News: